Phathom Pharmaceuticals (PHAT) Income Statement: Revenue & Earnings

Phathom Pharmaceuticals Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Phathom Pharmaceuticals, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	55.25	0.68	0.00	0.00	0.00
Cost of Revenue	7.97	0.17	0.00	0.00	0.00
Gross Profit	47.28	0.52	0.00	0.00	0.00
Operating Expenses
Research & Development	34.08	49.90	71.44	72.34	98.15
Selling, General & Administrative	290.66	117.93	101.00	62.74	27.52
Operating Expenses	324.75	167.83	172.44	135.08	125.67
Operating Income	-277.47	-167.31	-172.44	-135.08	-125.67
Other Income/Expense
Interest Income	15.16	7.88	2.13	0.04	1.09
Interest Expense	72.01	-41.97	-27.31	-6.79	-4.58
Other Income/Expense	-56.86	-0.19	-0.11	-0.06	0.09
Income
Income Before Tax	-334.33	-201.59	-197.72	-143.88	-129.07
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-334.33	-201.59	-197.72	-143.88	-129.07
Net Income - Continuous Operations	-334.33	-201.59	-197.72	-143.88	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-261.52	-166.74	-171.82	-134.56	-125.34
EBIT	-262.32	-167.31	-172.44	-135.08	-125.67
Depreciation & Amortization	0.80	0.58	0.62	0.52	0.32
Earnings Per Share
Basic EPS	-5.00	-4.00	-5.00	-4.00	-4.00
Diluted EPS	-5.00	-4.00	-5.00	-4.00	-4.00
Basic Shares Outstanding	63.18	51.29	39.12	37.00	33.23
Diluted Shares Outstanding	63.18	51.29	39.12	37.00	33.23